StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / minervax.com

MinervaX

MinervaX (minervax.com): 1 change recorded in its website history since February 2011. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeDeveloping a maternal vaccine against Group B Streptococcus
    AfterTowards the Development of Life-Saving Vaccines

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 1 February 2011

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Minervax - Frontpage

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2024 – November 2026 · 4 captures · latest observed messagingTowards the Development of Life-Saving Vaccines

    We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 24 July 2024 · Towards the Development of Life-Saving Vaccines archived page
    • 8 July 2025 · Towards the Development of Life-Saving Vaccines archived page
    • 14 September 2026 · Towards the Development of Life-Saving Vaccines archived page
    • 6 November 2026 · Towards the Development of Life-Saving Vaccines current websiteHistorical capture not publicly available
  2. April 2021 – February 2023 · 3 capturesDeveloping a maternal vaccine against Group B Streptococcus

    MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein: click to read more

    This wording observed 1 February 2023.

    archived page
    Inspect 3 captures in this group
    • 19 April 2021 · Developing a maternal vaccine against Group B Streptococcus archived page
    • 21 January 2022 · Developing a maternal vaccine against Group B Streptococcus archived page
    • 1 February 2023 · Developing a maternal vaccine against Group B Streptococcus archived page
  3. February 2011 – July 2018 · 4 capturesMinervax - Frontpage

    This wording observed 24 July 2018.

    archived page
    Inspect 4 captures in this group

Cite this record

StartupHistory, “MinervaX” company record, https://startuphistory.org/c/minervax.com

Machine-readable: /c/minervax.com.json. How changes are found: method.